A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age

被引：0
|
作者：
Lewis, D. [1 ]
Winner, P. [2 ]
Saper, J. [3 ]
Ness, S. [4 ]
Polverejan, E. [5 ]
Kurland, C. [6 ]
Ford, L. [4 ]
Eerdekens, M. [7 ]
机构：
[1] Childrens Hosp Kings Daughters, Eastern Virginia Med Sch, Div Pediat Neurol, Norfolk, VA USA
[2] Palm Beach Headache Ctr, W Palm Beach, FL USA
[3] Michigan Head Pain & Neurol Inst, Ann Arbor, MI USA
[4] Johnson & Johnson Pharmaceut Res & Dev LLC, CNS Pain & Translat Med, Titusville, NJ USA
[5] Johnson & Johnson Pharmaceut Res & Dev LLC, Clin Biostat, Titusville, NJ USA
[6] Johnson & Johnson Pharmaceut Res & Dev LLC, CNS Pain & Mature Prod TA Operat, Titusville, NJ USA
[7] Johnson & Johnson Pharmaceut Res & Dev LLC, CNS Analgesia, Antwerp, Belgium
来源：
HEADACHE | 2008年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S8 / S9
页数：2
相关论文
共 50 条
  • [1] Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Topiramate for Migraine Prevention in Pediatric Subjects 12 to 17 Years of Age
    Lewis, Donald
    Winner, Paul
    Saper, Joel
    Ness, Seth
    Polverejan, Elena
    Wang, Steven
    Kurland, Caryn L.
    Nye, Jeff
    Yuen, Eric
    Eerdekens, Marielle
    Ford, Lisa
    PEDIATRICS, 2009, 123 (03) : 924 - 934
  • [2] A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age
    Lewis, Donald
    Winner, Paul
    Saper, Joel
    Ness, Seth
    Polverejan, Elena
    Kurland, Caryn
    Ford, Lisa
    Eerdekens, Marielle
    NEUROLOGY, 2008, 70 (11) : A426 - A426
  • [3] Topiramate in migraine prevention: A double-blind, placebo-controlled study
    Storey, JR
    Calder, CS
    Hart, DE
    Potter, DL
    HEADACHE, 2001, 41 (10): : 968 - 975
  • [4] Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial
    Silberstein, Stephen D.
    Lipton, Richard B.
    Dodick, David W.
    Freitag, Frederick G.
    Ramadan, Nabih
    Mathew, Ninan
    Brandes, Jan L.
    Bigal, Marcelo
    Saper, Joel
    Ascher, Steven
    Jordan, Donna M.
    Greenberg, Steven J.
    Hulihan, Joseph
    HEADACHE, 2007, 47 (02): : 170 - 180
  • [5] Topiramate for migraine prevention in children: A randomized, double-blind, placebo-controlled trial
    Winner, P
    Pearlman, EM
    Linder, SL
    Jordan, DM
    Fisher, AC
    Hulihan, J
    HEADACHE, 2005, 45 (10): : 1304 - 1312
  • [6] Topiramate for the prevention of paediatric migraine: a randomized, double-blind, placebo-controlled trial
    Winner, P
    Pearlman, EM
    Linder, S
    Jordan, D
    Fisher, A
    Hulihan, J
    CEPHALALGIA, 2004, 24 (09) : 814 - 814
  • [7] Topiramate for migraine prevention: a randomized, double-blind, placebo-controlled, multiple-dose study
    Brandes, J
    Neto, W
    Jacobs, D
    Bhattacharaya, S
    CEPHALALGIA, 2003, 23 (07) : 694 - 694
  • [8] A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of AMG 334 for the Prevention of Episodic Migraine
    Sun, H.
    Silberstein, S.
    Dodick, D. W.
    Reuter, U.
    Ashina, M.
    Saper, J. R.
    Cady, R.
    Chon, Y.
    Dietrich, J.
    Lenz, R.
    HEADACHE, 2015, 55 : 132 - 132
  • [9] Efficacy of topiramate in migraine patients. Randomized, double-blind, placebo-controlled group
    Cho, SJ
    Lee, S
    Don, IH
    Yang, HD
    CEPHALALGIA, 2005, 25 (10) : 935 - 935
  • [10] Topiramate in the prophylaxis of pediatric migraine: A double-blind placebo-controlled trial
    Lakshmi, C. V. S.
    Singhi, Pratibha
    Malhi, Prahbhjot
    Ray, MLinni
    JOURNAL OF CHILD NEUROLOGY, 2007, 22 (07) : 829 - 835
12345